Cancer Family
Rare Childhood Malignant Neoplasm
CI-CAN-00000336Explore in graph →
Pediatric27 active trials
- NCIt
- C114451
Loading cancer entity…
Cancer Family
CI-CAN-00000336Explore in graph →
Clinical trials
76 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (4)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07709923 | Predictive Model For Anastomotic Leakage After Colorectal Cancer Surgery(Doesn't exist) | completed | — | 117 | University of FoggiaOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07512726 | DevelopmentA Web-Based Support Care Program for Individuals Diagnosed With Colorectal Cancer | completed | N/A | 24 | Ilknur YaziciogluOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT07213115 | Epidemiology and Treatment of Gastric Cancer | completed | — | 8,582 | Medizinische Hochschule Brandenburg Theodor FontaneOTHER | 0 | Oct 8, 2025 | clinicaltrials |
| NCT05581979 | PSMA-PET Imaging of Salivary Gland Tumours and Other Rare Cancers | completed | — | 4 | National Cancer Centre, SingaporeOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05934643 | An Observational Cohort Study to Assess the Postop Activity of Colorectal Patients Undergoing Elective Surgery (PHYSPAL)(PHYSPAL) | completed | — | 17 | University of NottinghamOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT06316882 | Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program(ROGCAS) | completed | — | 349 | Unidade Local De Saúde Do Norte AlentejanoOTHER | 1 | Feb 27, 2025 | clinicaltrials |
| NCT05917067 | Fluorescence Imaging of the Parathyroid Glands of Children(FLUOPATCH) | completed | — | 23 | Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)OTHER | 1 | Jan 30, 2025 | clinicaltrials |
| NCT05431621 | Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers | completed | — | 2,430 | Shanghai Zhongshan HospitalOTHER | 1 | Jan 29, 2025 | clinicaltrials |
| NCT00780494 | Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma | completed | Phase 2 | 35 | Stanford UniversityOTHER | 1 | Jan 14, 2025 | clinicaltrials |
| NCT06741124 | Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis | completed | — | 99 | Northern Jiangsu People's HospitalOTHER | 1 | Jan 10, 2025 | clinicaltrials |
| NCT06763068 | Skeletal Muscle Mass Used to Assess Frailty in Older Gastric Cancer Patients | completed | — | 575 | Nanjing Medical UniversityOTHER | 1 | Jan 8, 2025 | clinicaltrials |
| NCT06316401 | Endoscopic Submucosal Dissection of Large Recto-sigmoid Lesions Under Spinal Anesthesia | completed | — | 20 | Azienda USL ModenaOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT05933408 | TREM-1 - a New Marker of Serious Infectious Complications in Colorectal Surgery? | completed | — | 64 | Jagiellonian UniversityOTHER | 1 | Jul 7, 2023 | clinicaltrials |
| NCT02072486 | Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | completed | N/A | 30 | Roswell Park Cancer InstituteOTHER | 1 | Jul 25, 2022 | clinicaltrials |
| NCT00078858 | Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant | completed | Phase 1 / Phase 2 | 37 | Fred Hutchinson Cancer CenterOTHER | 3 | Jan 18, 2020 | clinicaltrials |
| NCT00027820 | Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | Phase 1 / Phase 2 | 106 | Fred Hutchinson Cancer CenterOTHER | 3 | Dec 20, 2019 | clinicaltrials |
| NCT00005799 | Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer | completed | N/A | 55 | Fred Hutchinson Cancer CenterOTHER | 2 | Sep 10, 2019 | clinicaltrials |
| NCT01502410 | Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer | completed | Phase 2 | 20 | National Cancer Institute (NCI)NIH | 3 | Jun 26, 2018 | clinicaltrials |
| NCT02042443 | Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery(S1310) | completed | Phase 2 | 53 | National Cancer Institute (NCI)NIH | 1 | Sep 12, 2017 | clinicaltrials |
| NCT00335556 | Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors | completed | Phase 2 | 291 | Children's Oncology GroupNETWORK | 5 | Jul 21, 2017 | clinicaltrials |
| NCT01135849 | B-Receptor Signaling in Cardiomyopathy | completed | — | 99 | Daniel BernsteinOTHER | 1 | Nov 17, 2015 | clinicaltrials |
| NCT00387920 | Sunitinib in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 35 | National Cancer Institute (NCI)NIH | 2 | Jan 28, 2014 | clinicaltrials |
| NCT00929903 | Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment | completed | Phase 1 | 55 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00994500 | Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00281944 | Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | completed | Phase 1 | 27 | National Cancer Institute (NCI)NIH | 2 | May 3, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Jul 17, 2026source: clinicaltrials